SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 116 filers reported holding SUTRO BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $217 | +4.8% | 62,579 | +40.7% | 0.00% | – |
Q2 2023 | $207 | -63.0% | 44,486 | -63.3% | 0.00% | – |
Q1 2023 | $559 | -15.4% | 121,144 | +47.9% | 0.00% | – |
Q4 2022 | $661 | -99.4% | 81,899 | +300.9% | 0.00% | – |
Q3 2022 | $114,000 | -8.8% | 20,429 | -14.3% | 0.00% | – |
Q2 2022 | $125,000 | -71.7% | 23,838 | -55.5% | 0.00% | – |
Q1 2022 | $441,000 | -95.8% | 53,591 | -92.4% | 0.00% | -100.0% |
Q4 2021 | $10,546,000 | +68.8% | 708,774 | +114.4% | 0.00% | -33.3% |
Q3 2021 | $6,247,000 | +40.6% | 330,624 | +38.3% | 0.00% | +50.0% |
Q2 2021 | $4,443,000 | -24.9% | 238,994 | -8.1% | 0.00% | -33.3% |
Q1 2021 | $5,919,000 | +18.5% | 260,123 | +13.0% | 0.00% | 0.0% |
Q4 2020 | $4,995,000 | +107.9% | 230,119 | -3.8% | 0.00% | +200.0% |
Q3 2020 | $2,403,000 | +30.5% | 239,125 | +0.7% | 0.00% | 0.0% |
Q2 2020 | $1,841,000 | -21.5% | 237,359 | +3.2% | 0.00% | -50.0% |
Q1 2020 | $2,346,000 | +1061.4% | 229,941 | +1156.6% | 0.00% | – |
Q4 2019 | $202,000 | +74.1% | 18,299 | +43.7% | 0.00% | – |
Q3 2019 | $116,000 | +4.5% | 12,732 | +30.9% | 0.00% | – |
Q2 2019 | $111,000 | +428.6% | 9,726 | +438.5% | 0.00% | – |
Q1 2019 | $21,000 | +133.3% | 1,806 | +80.8% | 0.00% | – |
Q4 2018 | $9,000 | – | 999 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |